News items that focus on evidence based practice
This theme explores what it means to practise in line with best available evidence. It highlights evidence based practice guidelines, research and other tools and updates on evidence based techniques and processes from across the UK. International content from credible resources is also included.
BMC Medical Informatics and Decision Making
“Hospital-acquired infections are still amongst the major problems health systems are facing. Their occurrence can lead to higher morbidity and mortality rates, increased length of hospital stay, and higher costs for both hospital and patients. Performing hand hygiene is a simple and inexpensive prevention measure, but healthcare workers’ compliance with it is often far from ideal.”
A male contraceptive gel has been found to work reliably in a trial in primates, bringing the prospect of an alternative form of birth control for humans closer. The product, called Vasalgel, is designed to be a reversible and less invasive form of vasectomy and in the latest study was 100 per cent effective at preventing conception. A blob of the gel is injected into the sperm-carrying tube, known as the vas deferens, and acts as a long-lasting barrier.
Despite strong evidence giving guidance for effective fall prevention interventions in community-residing older people, there is currently no clear model for engaging general medical practitioners in fall prevention and routine use of allied health professionals in fall prevention has been slow, limiting widespread dissemination. This protocol paper outlines an implementation-effectiveness study of the Integrated Solutions for Sustainable Fall Prevention (iSOLVE) intervention which has developed integrated processes and pathways to identify older people at risk of falls and engage a whole of primary care approach to fall prevention.
NHS England has launched a public consultation on how it will put in place new standards for hospitals providing congenital heart disease services in England. The consultation, which runs for 16 weeks from Thursday 9 February to Monday 5 June 2017, aims to gather as many views as possible from patients, families and clinical experts and will include face to face meetings around the country, webinars and an online survey.
NICE does not recommend breast cancer drug palbociclib (Ibrance, Pfizer) because its cost is too high in relation to its potential benefits in draft guidance out for consultation. Palbociclib (also called Ibrance and made by Pfizer) is used to treat hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer.
Three new statements have been added: Older people are to be asked about falls when at routine assessments and those at risk should be offered a multifactorial falls risk assessment. Those at increased risk of falling should have individualised multifactorial interventions.
NICE has advised health and care professionals to talk to older people about falls. NICE says routine appointments with family doctors, at hospital, or during home visits by social care workers, can prevent falls, disability and loss of independence.
This quality standard covers diagnosing and managing stable angina in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
Scottish Intercollegiate Guidelines Network
This guideline provides advice at all stages of the patient’s pathway of care, from primary prevention to early recognition, treatment and follow up. It does not address melanomas of non-cutaneous origin such as melanomas arising from mucosae.